James W.  McCollum net worth and biography

James McCollum Biography and Net Worth

Director of LENZ Therapeutics

James McCollum co-founded LENZ and has served on the LENZ board of directors since July 2013. From September 2016 to March 2021, Mr. McCollum served as LENZ’s President and Chief Executive Officer. From September 2014 to September 2016, Mr. McCollum served as President and Chief Executive Officer of Eye Therapies, LLC, an ocular pharmaceutical company co-founded by Mr. McCollum.

What is James W. McCollum's net worth?

The estimated net worth of James W. McCollum is at least $15.22 million as of May 13th, 2024. Mr. McCollum owns 525,565 shares of LENZ Therapeutics stock worth more than $15,220,362 as of May 14th. This net worth estimate does not reflect any other assets that Mr. McCollum may own. Learn More about James W. McCollum's net worth.

How old is James W. McCollum?

Mr. McCollum is currently 69 years old. There are 5 older executives and no younger executives at LENZ Therapeutics. The oldest executive at LENZ Therapeutics is Mr. Marvin J. Garrett, Senior Vice President of Regulatory & Quality, who is 73 years old. Learn More on James W. McCollum's age.

How do I contact James W. McCollum?

The corporate mailing address for Mr. McCollum and other LENZ Therapeutics executives is 611 Gateway Blvd Suite 120, SOUTH SAN FRANCISCO CA, 94080. LENZ Therapeutics can also be reached via phone at 650-484-0886 and via email at ir@graphitebio.com. Learn More on James W. McCollum's contact information.

Has James W. McCollum been buying or selling shares of LENZ Therapeutics?

James W. McCollum has not been actively trading shares of LENZ Therapeutics in the last ninety days. Most recently, on Monday, May 13th, James W. Mccollum bought 31,332 shares of LENZ Therapeutics stock. The stock was acquired at an average cost of $15.99 per share, with a total value of $500,998.68. Following the completion of the transaction, the director now directly owns 525,565 shares of the company's stock, valued at $8,403,784.35. Learn More on James W. McCollum's trading history.

James W. McCollum Insider Trading History at LENZ Therapeutics

See Full Table

James W. McCollum Buying and Selling Activity at LENZ Therapeutics

This chart shows James W Mccollum's buying and selling at LENZ Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$400k-$200k$0$200k$400kTotal Insider BuyingTotal Insider Selling

LENZ Therapeutics Company Overview

LENZ Therapeutics logo
LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.
Read More

Today's Range

Now: $28.96
Low: $28.09
High: $29.99

50 Day Range

MA: $24.82
Low: $18.32
High: $29.52

2 Week Range

Now: $28.96
Low: $14.42
High: $38.93

Volume

147,233 shs

Average Volume

186,226 shs

Market Capitalization

$815.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.41